- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Relapse and/or Refractory Multiple Myeloma in Belgium
Total 245 results
-
Bristol-Myers SquibbJanssen, LPActive, not recruitingMultiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin's LymphomaUnited States, Poland, Italy, Belgium, France, Greece
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, Netherlands, Belgium, Korea, Republic of, United Kingdom, Sweden, Denmark, Italy, Japan, Germany, France, Spain, Australia, Israel, Poland, Greece
-
PfizerRecruitingMultiple MyelomaUnited States, Japan, Finland, Norway, Spain, Sweden, Canada, Belgium, Italy, France, Germany, Brazil, Argentina, Czechia
-
CelgeneCompletedMultiple MyelomaNetherlands, Spain, Belgium, Austria, Switzerland, Italy, Germany, France, Ireland, United Kingdom, Denmark, Finland, Portugal, Turkey, Poland, Estonia, Greece, Norway, Slovakia, Sweden
-
Janssen Research & Development, LLCTerminatedMultiple MyelomaCanada, United States, Belgium, Poland, Italy, France, Spain, Brazil, Russian Federation, Denmark, Greece, Germany, Netherlands
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, Canada, Spain, Israel, United Kingdom, Germany, Austria, Belgium, France, Italy, Ireland, Netherlands, Sweden
-
Stichting European Myeloma NetworkJanssen Research & Development, LLCRecruitingMultiple MyelomaNetherlands, United States, Spain, Belgium, France, Italy, Germany, Japan, Canada, Australia, Sweden, Israel, United Kingdom, Czechia, Greece, Switzerland, Norway
-
CelgeneActive, not recruitingMultiple MyelomaNetherlands, Belgium, Denmark, Germany, United Kingdom, France, Norway, Spain, Austria, Ireland, Italy, Sweden
-
University Hospital, GhentBelgium Health Care Knowledge CentreCompleted
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, France, Poland, United Kingdom, Belgium, Spain, Germany, Portugal, Bulgaria, Romania, Netherlands, Greece, Canada, Russian Federation, Hungary, Brazil, Slovakia, Czechia
-
Celgene CorporationCompletedMultiple MyelomaUnited States, Spain, Australia, Canada, United Kingdom, Italy, Switzerland, Bulgaria, Poland, Ukraine, Belgium, Germany, Hungary, Ireland, Israel, Russian Federation
-
AmgenCompletedMultiple MyelomaBelgium, Austria, Czechia, Greece, Italy, France, Romania, Netherlands, Israel, Bulgaria, Norway
-
Oncopeptides ABTerminatedMultiple MyelomaUnited States, Austria, Belgium, Czechia, Denmark, Estonia, France, Greece, Hungary, Israel, Italy, Korea, Republic of, Lithuania, Netherlands, Norway, Poland, Romania, Russian Federation, Spain, Taiwan, United Kingdom
-
pharmaand GmbHCompletedMultiple MyelomaCanada, Spain, United States, Czechia, Turkey, France, Sweden, Korea, Republic of, Thailand, Belgium, Greece, Germany, Hungary, Russian Federation, Italy, Poland, Australia, Lebanon, Portugal, Norway, Brazil, Netherlands
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaGermany, Korea, Republic of, Belgium, Israel, Australia, United Kingdom, France, Sweden, Spain, Turkey, Italy, Japan, Czechia, Brazil, Netherlands, Poland, Portugal, Switzerland, Norway, Greece, China, Canada
-
CelgeneCompletedMultiple MyelomaUnited States, Netherlands, Canada, Belgium, United Kingdom, Australia, Denmark, Germany, Spain, Switzerland, France, Italy, Greece, Russian Federation, Sweden, Czechia
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaUnited States, Korea, Republic of, Czechia, Israel, Switzerland, Belgium, United Kingdom, Japan, Canada, Spain, Sweden, Germany, Australia, Netherlands, France, Argentina, Brazil, Denmark, Greece, Poland, Ireland, Hungary, Portugal, F... and more
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaUnited States, Australia, Spain, Bulgaria, Poland, Belgium, France, Germany, Italy, Hungary, United Kingdom, Greece, Russian Federation, Brazil, China, Korea, Republic of, Japan, Canada, Netherlands
-
TakedaCompletedMultiple MyelomaUnited States, Spain, United Kingdom, Belgium, Taiwan, Italy, Israel, China, Turkey, Germany, Greece, Mexico, Colombia, France, Brazil
-
Intergroupe Francophone du MyelomeJanssen Research & Development, LLC; HOVON - Dutch Haemato-Oncology AssociationActive, not recruitingMultiple MyelomaNetherlands, France, Belgium
-
Stichting European Myeloma NetworkFondazione EMN Italy OnlusCompletedCovid19 | Multiple Myeloma | Corona Virus InfectionCzechia, Netherlands, United Kingdom, Belgium, Germany, Austria, Greece, Italy
-
Janssen Research & Development, LLCCompletedMultiple MyelomaAustralia, France, Poland, United Kingdom, United States, Spain, Israel, Portugal, South Africa, Canada, Netherlands, Belgium, Singapore, Russian Federation, Czech Republic, Argentina, Austria
-
University Hospital, GhentUniversitaire Ziekenhuizen KU Leuven; University of Liege; Universitair Ziekenhuis... and other collaboratorsActive, not recruitingInfertility | Adhesion | Hysteroscopy | Myoma;Uterus | Uterine Septum | Polyp Uterus | Retained Products of ConceptionBelgium
-
Novartis PharmaceuticalsCompletedTuberous Sclerosis Complex-associated Refractory SeizuresUnited States, Colombia, Belgium, France, Japan, Taiwan, Turkey, Spain, Thailand, Korea, Republic of, Australia, Hungary, United Kingdom, Canada, Norway, Germany, Italy, Russian Federation, Denmark, Argentina, Netherlands, Greece, P... and more
-
AmgenCompletedMultiple MyelomaCanada, Denmark, Finland, France, Italy, Spain, Sweden, United Kingdom, Czechia, Poland, United States, Belgium, Hungary, New Zealand, Australia, Germany, Japan, Greece, Norway, Romania
-
Stichting Hemato-Oncologie voor Volwassenen NederlandEuropean Myeloma Network; Gruppo Italiano Malattie EMatologiche dell'Adulto; DSMM... and other collaboratorsActive, not recruitingMultiple MyelomaSweden, Norway, Italy, Netherlands, Belgium, Switzerland, Australia, Denmark, Finland, Czechia, Turkey, Austria, Luxembourg, Hungary, Greece, Portugal
-
ADC Therapeutics S.A.RecruitingRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaJapan, Belgium, France, Italy, Spain, United Kingdom, United States, Israel, Hungary, Brazil, Switzerland, Poland, Canada, Puerto Rico, Czechia, Netherlands, China, Mexico, Argentina, Chile, Turkey
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaCanada, United States, Belgium, Korea, Republic of, United Kingdom, Sweden, Italy, Denmark, Japan, Taiwan, China, Germany, Spain, France, Netherlands, Turkey, Russian Federation, Poland, Greece, Argentina, Brazil
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaAustralia, Japan, Spain, Germany, Poland, Belgium, Israel, Italy, Russian Federation, Canada, New Zealand, Korea, Republic of, China, Brazil, Czechia, United States, Netherlands, United Kingdom, Greece, France
-
Karyopharm Therapeutics IncActive, not recruitingMultiple MyelomaUnited States, United Kingdom, Australia, Israel, Canada, Belgium, Austria, Czechia, Serbia, India, France, Italy, Russian Federation, Bulgaria, Germany, Greece, Hungary, Poland, Romania, Spain, Ukraine
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, Australia, France, Poland, United Kingdom, Belgium, Germany, Taiwan, Spain, Israel, Japan, Canada, Netherlands, Denmark, Sweden, Korea, Republic of, Russian Federation, Greece
-
Janssen Research & Development, LLCActive, not recruitingHematological MalignanciesCanada, United States, France, Italy, United Kingdom, Germany, Belgium, Netherlands, Spain, Sweden, China
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, France, Korea, Republic of, Canada, Belgium, New Zealand, Russian Federation
-
CelgeneBristol-Myers SquibbRecruitingMultiple MyelomaAustria, United States, Spain, Australia, Japan, France, Israel, Italy, Canada, Greece, Belgium, Norway, Romania, Czechia, Denmark, Germany, Korea, Republic of, United Kingdom, Poland
-
CelgeneBristol-Myers SquibbRecruitingMultiple MyelomaAustria, Denmark, United States, Spain, Australia, Japan, France, Korea, Republic of, Israel, Italy, Canada, Greece, Belgium, Norway, Romania, United Kingdom, Czechia, Germany, Poland
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaAustralia, Poland, United Kingdom, United States, Belgium, Germany, Spain, Argentina, Portugal, Bulgaria, Romania, Serbia, Turkey, Ukraine, Japan, Greece, Korea, Republic of, Brazil, Russian Federation, Hungary, Czechia, Croatia, Ge... and more
-
Janssen Research & Development, LLCCompletedNeoplasms | Neoplasms, Breast | Neoplasms, Ovarian | Advanced or Refractory Solid MalignanciesUnited States, United Kingdom, Spain, Belgium
-
Bristol-Myers SquibbAbbVieCompletedMultiple MyelomaUnited States, Australia, Austria, Belgium, Canada, Czechia, Germany, Greece, Hungary, Ireland, Israel, Italy, Poland, Puerto Rico, Romania, Russian Federation, Spain, Switzerland, Turkey, United Kingdom
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, France, United Kingdom, Belgium, Germany, Israel, Australia, Sweden, Canada, Netherlands, Austria, Ireland, Denmark
-
AmgenCompletedMultiple MyelomaKorea, Republic of, China, Spain, Taiwan, United States, Netherlands, Australia, Singapore, New Zealand, United Kingdom, Israel, France, Japan, Italy, Czechia, Belgium, Argentina, Austria, Bulgaria, Canada, Germany, Greece, Hungary, M... and more
-
Bristol-Myers SquibbRecruitingMultiple MyelomaCanada, Taiwan, United States, Australia, Denmark, China, Korea, Republic of, Israel, Spain, France, Germany, Czechia, Austria, Japan, Sweden, United Kingdom, Greece, Italy, Finland, Argentina, Belgium, Brazil, Colombia, Hong Kong, India, Mexic... and more
-
CelgeneRecruitingMultiple MyelomaAustria, Italy, China, Australia, Spain, United States, Korea, Republic of, Taiwan, Germany, Ireland, Argentina, Brazil, Mexico, Netherlands, Belgium, Czechia, France, Greece, Japan, Poland, Israel, United Kingdom, Norway, Denmark, Finland and more
-
CelgeneWithdrawnMultiple MyelomaChina, Australia, United States, Argentina, Austria, Belgium, Brazil, Canada, Chile, Czechia, France, Germany, Greece, Hungary, India, Ireland, Italy, Japan, Korea, Republic of, Norway, Portugal, Romania, Spain, Sweden, Switzerland, Turkey, United Kingdom
-
PfizerRecruitingMultiple MyelomaJapan, Belgium, United States, Netherlands, Australia, Austria, Taiwan, China, Spain, Canada, Israel, Germany, Italy, Czechia, Korea, Republic of, Norway, Finland, Sweden, Brazil, Greece, Turkey, France, United Kingdom, Hungary, Poland, I...
-
Novartis PharmaceuticalsCompletedMultiple MyelomaChina, United States, Italy, Taiwan, Egypt, Japan, Turkey, Germany, Netherlands, Canada, Australia, Austria, Israel, Sweden, United Kingdom, Korea, Republic of, Spain, Hong Kong, Thailand, France, Belgium, Norway, South Africa, Brazil, ... and more
-
TakedaCompletedMultiple MyelomaFrance, Spain, United States, Taiwan, Korea, Republic of, Israel, Australia, Czechia, Hungary, Canada, Japan, Portugal, Singapore, United Kingdom, Italy, Sweden, Poland, Germany, China, Denmark, Greece, Thailand, Serbia, Turkey, Colombia, Russian Federation and more
-
AmgenCompletedMultiple MyelomaKorea, Republic of, Spain, Taiwan, Canada, Australia, Israel, Italy, United States, Singapore, New Zealand, Japan, Thailand, Brazil, United Kingdom, Hungary, Czechia, Romania, Slovakia, France, Germany, Russian Federation, Bulgaria, Belgiu... and more
-
PfizerRecruitingMultiple MyelomaChina, Korea, Republic of, Taiwan, United States, France, Sweden, Australia, Japan, Spain, Czechia, United Kingdom, Canada, Germany, New Zealand, Italy, Poland, Netherlands, Austria, Mexico, Finland, Argentina, Belgium, Brazil, Greece, ... and more
-
Janssen Research & Development, LLCRecruitingHematological MalignanciesUnited States, Belgium, Korea, Republic of, China, Germany, Israel, Netherlands, Japan, Spain, France, Poland
-
Bristol-Myers SquibbAbbVieCompletedLymphoma | Multiple MyelomaUnited States, Belgium, France, Germany, Italy, Japan, United Kingdom, Australia, Poland, Puerto Rico, Canada, Denmark, Hungary, Israel, Spain, Czechia, Ireland, Austria, Switzerland, Greece, Turkey, Romania, United Arab Emirates